Ferric carboxymaltose has become the first form of intravenous iron replacement to earn a US Food and Drug Administration indication for heart failure, the manufacturer announced today. Injectafer ...

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...

Trials such as HEART-FID and AFFIRM-AHF have demonstrated positive treatment results for injectable ferric carboxymaltose in patients with heart failure and iron deficiency. On June 5, 2023, the FDA ...

Phosphate Binders Cut Mortality, Up ESRD Risk In hemodialysis patients with high ferritin levels at baseline, the iron-based phosphate binder ferric citrate increased mean transferrin saturation from ...

Please provide your email address to receive an email when new articles are posted on . Patients with iron deficiency anemia and chronic kidney disease had increased hemoglobin levels with ferric ...